Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
-0.32%
SPX
-0.01%
IXIC
+0.05%
FTSE
+0.22%
N225
-0.21%
AXJO
+1.37%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Overview

Loading chart...

Recently from Cashu

publisher logo
Cashu

Altimmune's Data Privacy Challenge: Lessons from Meta's Trial for Biotech Firms

2 days ago
publisher logo
Cashu

Altimmune's Innovative Immunotherapy Progress Amid Market Volatility and Health Challenges

8 days ago
publisher logo
Cashu

Altimmune's Immunotherapy Strategy Thrives Amid Economic Uncertainty and Market Volatility

9 days ago

Key Stats

Market Cap
314.22M
Dividend Yield
0.00%
P/E Ratio
-3.48
EPS
-1.34
Revenue
20.00K
Avg. Volume
2.43M

About

What does ALT do?
Altimmune, a clinical-stage biopharmaceutical company in Gaithersburg, Maryland, develops peptide-based therapeutics for obesity and liver diseases, including the lead candidate pemvidutide. The company has completed Phase II trials for both pemvidutide and HepTcell, targeting metabolic dysfunction and hepatitis B.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
Maryland, USA
Website
http://altimmune.com
Stocks
Health Care
alt
Altimmune
ALT
+0.03 (+0.74%)
4.08
USD
At close at Jul 18, 20:42 UTC
Summary
News
Signals
Benchmarks
Financials